What is the treatment for urticaria (hives) in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urticaria (Hives) in Children

H1 antihistamines are the mainstay of treatment for urticaria in children, with second-generation non-sedating antihistamines being the first-line therapy. 1

First-Line Treatment

  • Second-generation H1 antihistamines (non-sedating) are the cornerstone of urticaria management in children due to their efficacy in controlling symptoms with minimal side effects 1, 2

    • Options include cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine 1
    • These medications should be offered as the initial treatment for all children with urticaria 1
  • For children who don't respond adequately to standard doses, increasing the dose of second-generation H1 antihistamines above the manufacturer's licensed recommendation may be considered when benefits outweigh risks 1

Second-Line and Adjunctive Treatments

  • For cases resistant to standard doses of second-generation antihistamines, consider these approaches:

    • Combination therapy with H1 and H2 antihistamines (such as ranitidine or famotidine) can be effective for controlling severe pruritus and wheal formation 1
    • Addition of a sedating antihistamine (such as diphenhydramine or hydroxyzine) at night can help with sleep disruption from pruritus 1
    • Leukotriene receptor antagonists (e.g., montelukast) may be added as adjunctive therapy for resistant cases 1, 2
  • Short courses of oral corticosteroids should be restricted to severe acute urticaria or angioedema affecting the mouth 1, 3

    • The evidence for adding corticosteroids to antihistamines in acute urticaria is mixed, with most studies showing no additional benefit 3

Management Considerations

  • Identify and avoid triggering factors when possible 1, 4

    • Common triggers include hot temperatures, tight clothing, stress/anxiety, and certain medications (especially NSAIDs and aspirin) 1, 4
    • In cases of physical urticaria, identifying the specific physical stimulus allows for lifestyle modifications 1
  • Cooling antipruritic lotions, such as calamine or 1% menthol in aqueous cream, can provide symptomatic relief 1

  • For urticaria associated with mastocytosis, temperature control is particularly important as mast cells can be activated by hot and cold temperatures 1

Special Considerations

  • Duration of individual wheals is diagnostically important:

    • Ordinary urticaria wheals typically last 2-24 hours 1
    • Physical urticaria wheals usually resolve within an hour (except delayed pressure urticaria) 1
    • Wheals lasting longer than 24 hours may suggest urticarial vasculitis and warrant skin biopsy 1
  • Most cases of acute urticaria resolve within 6 months, but those with both wheals and angioedema may have a more prolonged course 1

Treatment-Resistant Cases

  • For chronic urticaria unresponsive to optimal antihistamine therapy, referral to a specialist may be necessary for consideration of:

    • Omalizumab (anti-IgE antibody) for antihistamine-refractory cases 5
    • Cyclosporine for severe, refractory cases (though this carries more significant side effects) 5, 6
  • Immunomodulating therapies should be restricted to patients with disabling disease who have not responded to conventional treatments 1

Pitfalls and Caveats

  • Avoid first-generation H1 antihistamines as first-line therapy due to their sedative effects, which can impact school performance and cognitive function 1
  • NSAIDs should be avoided in aspirin-sensitive patients with urticaria due to risk of cross-reactions 1
  • Extensive laboratory workup is unnecessary for most cases of urticaria unless specific underlying conditions are suggested by history or physical examination 2
  • Remember that chronic urticaria is idiopathic in 80-90% of cases, so focusing on symptom management rather than extensive testing for causes is often more beneficial 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Research

Treatment of acute urticaria: A systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Research

Urticaria: Diagnosis and Management.

Primary care, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.